BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in Exeter, the United Kingdom.
BioPharma Credit Dividend Announcement
• BioPharma Credit announced a quarterly dividend of $0.02 per ordinary share which will be made payable on 2024-10-29. Ex dividend date: 2024-09-26
• BioPharma Credit annual dividend for 2024 was $0.08
• BioPharma Credit annual dividend for 2023 was $0.09
• BioPharma Credit's trailing twelve-month (TTM) dividend yield is 13.87%
• BioPharma Credit's payout ratio for the trailing twelve months (TTM) is 119.60%
• BioPharma Credit's dividend growth over the last five years (2018-2023) was 8.20% year
BioPharma Credit Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-09-26 | $0.02 | quarterly | 2024-10-29 |
2024-07-04 | $0.02 | quarterly | 2024-07-31 |
2024-03-28 | $0.02 | quarterly | |
2024-02-15 | $0.03 | quarterly | |
2023-12-07 | $0.04 | quarterly | 2024-01-05 |
2023-08-17 | $0.02 | quarterly | 2023-09-15 |
2023-04-27 | $0.02 | quarterly | 2023-05-26 |
2023-03-30 | $0.02 | quarterly | 2023-04-28 |
2022-10-20 | $0.04 | quarterly | 2022-11-18 |
2022-08-25 | $0.02 | quarterly | 2022-09-23 |
2022-05-05 | $0.02 | quarterly | 2022-05-31 |
2022-03-03 | $0.02 | quarterly | 2022-03-31 |
2021-11-18 | $0.02 | quarterly | 2021-12-17 |
2021-08-19 | $0.02 | quarterly | 2021-09-17 |
2021-06-03 | $0.02 | quarterly | 2021-06-30 |
2021-03-18 | $0.00 | quarterly | 2021-04-16 |
2020-11-19 | $0.00 | quarterly | 2020-12-18 |
2020-08-20 | $0.02 | quarterly | 2020-09-18 |
2020-05-21 | $0.02 | quarterly | 2020-06-19 |
2020-02-27 | $0.01 | quarterly | 2020-03-27 |
2019-11-14 | $0.02 | quarterly | 2019-12-17 |
2019-08-15 | $0.02 | quarterly | 2019-09-20 |
2019-05-23 | $0.02 | quarterly | 2019-06-21 |
2019-02-28 | $0.00 | quarterly | 2019-03-29 |
2018-11-01 | $0.02 | quarterly | 2018-11-30 |
2018-08-30 | $0.02 | quarterly | 2018-09-28 |
2018-05-31 | $0.01 | quarterly | 2018-06-29 |
2018-03-08 | $0.01 | quarterly | 2018-03-29 |
2017-12-14 | $0.01 | quarterly | 2018-01-31 |
2017-09-28 | $0.01 | quarterly | 2017-10-31 |
BioPharma Credit Dividend per year
BioPharma Credit Dividend growth
BioPharma Credit Dividend Yield
BioPharma Credit current trailing twelve-month (TTM) dividend yield is 13.87%. Interested in purchasing BioPharma Credit stock? Use our calculator to estimate your expected dividend yield:
BioPharma Credit Financial Ratios
BioPharma Credit Dividend FAQ
Other factors to consider when evaluating BioPharma Credit as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy BioPharma Credit stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: BioPharma Credit's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, BioPharma Credit publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, BioPharma Credit distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from BioPharma Credit are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: BioPharma Credit sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, BioPharma Credit distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: BioPharma Credit declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of BioPharma Credit's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review BioPharma Credit's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.